Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Verified Market Research | PRODUCT CODE: 1628649

Cover Image

PUBLISHER: Verified Market Research | PRODUCT CODE: 1628649

Global Artificial Tendons And Ligaments Market Size By Type of Product, By Application, By End-User, By Geographic Scope And Forecast

PUBLISHED:
PAGES: 202 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
Unprintable PDF (Single User License)
USD 3950
Unprintable PDF & Excel (Multi User License)
USD 4850
PDF & Excel (Enterprise User License)
USD 7550

Add to Cart

Artificial Tendons And Ligaments Market Size And Forecast

Artificial Tendons And Ligaments Market size was valued at USD 77.91 Million in 2024 and is projected to reach USD 168.22 Million by 2031, growing at a CAGR of 10.1% during the forecast period 2024-2031.

Global Artificial Tendons And Ligaments Market Drivers

The market drivers for the Artificial Tendons And Ligaments Market can be influenced by various factors. These may include:

Growing Sports Injuries: As engagement in physical activities and sports increases, so does the frequency of sports-related injuries, such as abrasions to tendons and ligaments. This fuels the need for sophisticated medical procedures such as prosthetic ligaments and tendons.

Growing Senior Population: As the world's population ages, age-related tendon and ligament damage, including osteoarthritis, is becoming more common. For this population, options for regaining mobility and function include artificial tendons and ligaments.

Technological developments: More complex and long-lasting artificial tendons and ligaments have been created thanks to developments in biomaterials, tissue engineering, and surgical methods. Patients looking for better treatment alternatives are drawn to these developments as well as healthcare professionals.

Preference for Minimally Invasive Surgery: Because these procedures have shorter recovery times and a decreased risk of complications, both patients and surgeons are beginning to favour them more and more. The acceptance of artificial tendons and ligaments is fueled by the ease with which they may be inserted through minimally invasive methods.

Growing Healthcare Expenditure: Access to cutting-edge medical therapies like artificial tendons and ligaments is made easier by rising healthcare spending globally, particularly in industrialised nations. By making these operations more affordable for patients, this promotes market expansion.

Growing Knowledge and Education: Patients are encouraged to seek proper medical care, including artificial implants where necessary, as a result of growing knowledge regarding the significance of prompt treatment for tendon and ligament injuries as well as educational campaigns on available treatment alternatives.

Sports Medicine Advancements: With athletes striving for a quick recovery and return to play, there is a greater need for effective treatment options like artificial tendons and ligaments. These advancements in sports medicine include improved rehabilitation methods and injury prevention strategies.

Regulatory Environment: The dynamics of the market are greatly influenced by the regulatory environment. Tight restrictions guarantee artificial implants' safety and effectiveness, but they can also affect product development timeframes and market entry hurdles.

Global Artificial Tendons And Ligaments Market Restraints

Several factors can act as restraints or challenges for the Artificial Tendons And Ligaments Market. These may include:

High Cost: The development, production, and acquisition of artificial tendons and ligaments can be costly. Patients may find it more difficult to get this expensive treatment, especially in areas with little healthcare resources or for those without sufficient insurance.

Regulatory Difficulties: Strict regulatory scrutiny is involved in the development and approval process for medical devices, including prosthetic tendons and ligaments. Obtaining regulatory permission can be complicated or delayed, which can hinder market access and raise expenses for producers.

Limited Clinical Evidence: When compared to conventional treatment choices, there may not be as much long-term clinical data demonstrating the safety and effectiveness of artificial tendons and ligaments, despite technological developments. Patients and healthcare professionals may be reluctant to use these products as a result of the weak evidence.

Complex Surgical Techniques: Specialised surgical instruments and abilities are frequently needed for the implantation of artificial tendons and ligaments. In order to carry out these treatments successfully, surgeons might need extra training, which could prevent their broad acceptance, especially in areas where there is a scarcity of qualified medical experts.

Risk of Complications: Implanting artificial tendons and ligaments carries some inherent risks, similar to any surgical treatment, such as infection, implant rejection, and implant failure. These hazards might discourage medical professionals and patients from selecting these treatments over more traditional ones.

Limited Reimbursement: In certain healthcare systems, patients or healthcare providers may not be able to afford prosthetic tendons and ligaments due to inadequate reimbursement policies covering associated costs.

Ethical Issues: Using artificial materials in orthopaedic treatments may raise ethical questions, especially when there are natural tissue substitutes available. Certain patients and healthcare providers can have a preference for cautious methods or harbour doubts regarding the enduring consequences of utilising artificial implants.

Global Artificial Tendons And Ligaments Market Segmentation Analysis

The Global Artificial Tendons And Ligaments Market is Segmented on the basis of Type of Product, Application, End-User, and Geography.

Artificial Tendons And Ligaments Market, By Type of Product

  • Synthetic Ligaments: Artificial ligaments made from synthetic materials such as polyester, polyethylene, or polypropylene.
  • Synthetic Tendons: Artificial tendons fabricated from synthetic materials to replace or augment damaged natural tendons.
  • Allografts: Tendons or ligaments harvested from human cadavers and processed for transplantation.
  • Xenografts: Tendons or ligaments sourced from animals, such as pigs or cows, and treated for implantation in humans.

Artificial Tendons And Ligaments Market, By Application

  • Orthopedic Injuries: Treatment of ligament and tendon injuries in joints such as the knee, shoulder, ankle, and elbow.
  • Sports Injuries: Management of ligament and tendon injuries sustained during sports activities, including ACL tears and rotator cuff injuries.
  • Trauma Cases: Reconstruction of ligaments and tendons damaged due to trauma or accidents.
  • Other Medical Conditions: Utilization of artificial tendons and ligaments in other medical conditions, such as arthritis or degenerative joint diseases.

Artificial Tendons And Ligaments Market, By End-User

  • Hospitals: Including orthopedic departments and surgical centers where artificial tendons and ligaments are implanted.
  • Ambulatory Surgical Centers (ASCs): Facilities specializing in outpatient procedures, including orthopedic surgeries.
  • Sports Medicine Clinics: Centers focusing on the diagnosis, treatment, and rehabilitation of sports-related injuries.
  • Specialty Clinics: Orthopedic or musculoskeletal clinics providing specialized care for ligament and tendon injuries.

Artificial Tendons And Ligaments Market, By Geography

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

Key Players

  • The major players in the Artificial Tendons And Ligaments Market are:
  • Neoligaments
  • Orthomed S.A.S
  • Corin Group
  • Arthrex Inc
  • Cousin Biotech
  • Mathys AG Bettlach
  • FX Solutions
  • LARS
  • Cousin Biotech
  • Shanghai PINE&POWER Biotech
  • Stryker Corporation.
Product Code: 29087

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL ARTIFICIAL TENDONS AND LIGAMENTS MARKET

  • 1.1 Market Definition
  • 1.2 Market Segmentation
  • 1.3 Research Timelines
  • 1.4 Assumptions
  • 1.5 Limitations

2 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

  • 2.1 Data Mining
  • 2.2 Data Triangulation
  • 2.3 Bottom-Up Approach
  • 2.4 Top-Down Approach
  • 2.5 Research Flow
  • 2.6 Key Insights from Industry Experts
  • 2.7 Data Sources

3 EXECUTIVE SUMMARY

  • 3.1 Market Overview
  • 3.2 Ecology Mapping
  • 3.3 Absolute Market Opportunity
  • 3.4 Market Attractiveness
  • 3.5 Global Artificial Tendons And Ligaments Market Geographical Analysis (CAGR %)
  • 3.6 Global Artificial Tendons And Ligaments Market, By Application (USD Million)
  • 3.7 Global Artificial Tendons And Ligaments Market, By End-User (USD Million)
  • 3.8 Future Market Opportunities
  • 3.10 Global Market Split
  • 3.10 Product Life Line

4 GLOBAL ARTIFICIAL TENDONS AND LIGAMENTS MARKET OUTLOOK

  • 4.1 Global Artificial Tendons And Ligaments Evolution
  • 4.2 Drivers
    • 4.2.1 Driver 1
    • 4.2.2 Driver 2
  • 4.3 Restraints
    • 4.3.1 Restraint 1
    • 4.3.2 Restraint 2
  • 4.4 Opportunities
    • 4.4.1 Opportunity 1
    • 4.4.2 Opportunity 2
  • 4.5 Porters Five Force Model
  • 4.6 Value Chain Analysis
  • 4.7 Pricing Analysis
  • 4.8 Macroeconomic Analysis

5 GLOBAL ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY TYPE OF PRODUCT

  • 5.1 o Synthetic Ligaments
  • 5.2 o Synthetic Tendons
  • 5.3o Allografts
  • 5.4 o Xenografts

6 GLOBAL ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY APPLICATION

  • 6.1 o Orthopedic Injuries
  • 6.2 o Sports Injuries
  • 6.3 o Trauma Cases
  • 6.4.o Other Medical Conditions

7 GLOBAL ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY END-USER

  • 7.1 o Hospitals
  • 7.2 o Ambulatory Surgical Centers (ASCs)
  • 7.3 o Sports Medicine Clinics
  • 7.4 o Specialty Clinics

8 GLOBAL ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY GEOGRAPHY

  • 8.1 Overview
  • 8.2 North America

8. 2.1 U.S.

    • 8.2.2 Canada
    • 8.2.3 Mexico
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 U.K.
    • 8.3.3 France
    • 8.3.4 Italy
    • 8.3.5 Spain
    • 8.3.6 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 India
    • 8.4.4 Rest of Asia Pacific
  • 8.5 Latin America
    • 8.5.1 Brazil
    • 8.5.2 Argentina
    • 8.5.3 Rest of Latin America
  • 8.6 Middle-East and Africa
    • 8.6.1 UAE
    • 8.6.2 Saudi Arabia
    • 8.6.3 South Africa
    • 8.6.4 Rest of Middle-East and Africa

9 GLOBAL ARTIFICIAL TENDONS AND LIGAMENTS MARKET COMPETITIVE LANDSCAPE

  • 9.1 Overview
  • 9.2 Company Market Ranking
  • 9.3 Key Developments
  • 9.4 Company Regional Footprint
  • 9.5 Company Industry Footprint
  • 9.6 ACE Matrix

10 COMPANY PROFILES

  • 10.1 Neoligaments
    • 10.1.1 Company Overview
    • 10.1.2 Company Insights
    • 10.1.3 Product Benchmarking
    • 10.1.4 Key Development
    • 10.1.5 Winning Imperatives
    • 10.1.6 Current Focus & Strategies
    • 10.1.7 Threat from Competition
    • 10.1.8 SWOT Analysis
  • 10.2 Orthomed S.A.S
    • 10.2.1 Company Overview
    • 10.2.2 Company Insights
    • 10.2.3 Product Benchmarking
    • 10.2.4 Key Development
  • 10.3 Corin Group
    • 10.3.1 Company Overview
    • 10.3.2 Company Insights
    • 10.3.3 Product Benchmarking
    • 10.3.4 Key Development
  • 10.4 Arthrex Inc.
    • 10.4.1 Company Overview
    • 10.4.2 Company Insights
    • 10.4.3 Product Benchmarking
    • 10.4.4 Key Development
  • 10.5 Cousin Biotech
    • 10.5.1 Company Overview
    • 10.5.2 Company Insights
    • 10.5.3 Product Benchmarking
    • 10.5.4 Key Development
  • 10.6 Mathys AG Bettlach
    • 10.6.1 Company Overview
    • 10.6.2 Company Insights
    • 10.6.3 Product Benchmarking
    • 10.6.4 Key Development
  • 10.7 FX Solutions
    • 10.7.1 Company Overview
    • 10.7.2 Company Insights
    • 10.7.3 Product Benchmarking
    • 10.7.4 Key Development
  • 10.8 LARS
    • 10.8.1 Company Overview
    • 10.8.2 Company Insights
    • 10.8.3 Product Benchmarking
    • 10.8.4 Key Development
  • 10.10 Cousin Biotech
    • 10.1010.1 Company Overview
    • 10.10.2 Company Insights
    • 10.10.3 Product Benchmarking
    • 10.10.4 Key Development
  • 10.10 Shanghai PINE&POWER Biotech
    • 10.10.1 Company Overview
    • 10.10.2 Company Insights
    • 10.10.3 Product Benchmarking
    • 10.10.4 Key Development
  • 10.11 Stryker Corporation
    • 10.11.1 Company Overview
    • 10.11.2 Company Insights
    • 10.11.3 Product Benchmarking
    • 10.11.4 Key Development

10. VERIFIED MARKET INTELLIGENCE

  • 10.1 About Verified Market Intelligence
  • 10.2 Dynamic Data Visualization

10. COMPANY PROFILES

11. 1 Amadeus

12. MARKET OUTLOOK AND OPPORTUNITIES

  • 12.1 Emerging Technologies
  • 12.2 Future Market Trends

12. 3 Investment Opportunities

13. APPENDIX

  • 13.1 List Of Abbreviations
  • 13.2 Sources And References
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!